百济神州超越恒瑞医药,成为新一代“药王”

Ofweek维科网
07 Mar

医药行业,迎来史无前例的巨变。百济神州市值超越恒瑞医药,成为国内当之无愧的“医药一哥”。截至3月6日收盘,A股百济神州的市值高达3238亿元,比恒瑞医药市值(2968亿)要高上270亿元,为何百济神州成为投资者眼中的香饽饽?又能否稳坐高位呢?百济神州的成长性、研发投入远超恒瑞医药,且规模已经迎头赶上,从这一点来看无愧于新一代“药王”的美誉,不过,百济神州高度分散的股权、亏损问题仍需引起重视,这一点...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10